Similar articles

• Distribution and metabolism of rubidazone and daunorubicin in mice.

  Baurain R, Deprez-De Campeneere D, Trouet A. Baurain R, et al. Cancer Chemother Pharmacol. 1979;2(1):37-41. doi: 10.1007/BF00253103. Cancer Chemother Pharmacol. 1979. PMID: 498418
• Microbial reduction of the side-chain carbonyl of daunorubicin and N-acetyldaunorubicin.

  Aszalos AA, Bachur NR, Hamilton BK, Langlykke AF, Roller PP, Sheikh MY, Sutphin MS, Thomas MC, Wareheim DA, Wright LH. Aszalos AA, et al. J Antibiot (Tokyo). 1977 Jan;30(1):50-8. doi: 10.7164/antibiotics.30.50. J Antibiot (Tokyo). 1977. PMID: 838632
• Metabolism of the anthracycline antibiotic daunorubicin to daunorubicinol and deoxydaunorubicinol aglycone in hepatocytes isolated from the rat and the rabbit.

  Gewirtz DA, Yanovich S. Gewirtz DA, et al. Biochem Pharmacol. 1986 Nov 15;35(22):4059-64. doi: 10.1016/0006-2952(86)90028-6. Biochem Pharmacol. 1986. PMID: 3778526
• Daunorubicin and daunorubicinol pharmacokinetics in plasma and tissues in the rat.

  Cusack BJ, Young SP, Olson RD. Cusack BJ, et al. Cancer Chemother Pharmacol. 1995;35(3):213-8. doi: 10.1007/BF00686550. Cancer Chemother Pharmacol. 1995. PMID: 7805179
• [Pharmacokinetics of new anthracyclines].

  Robert J. Robert J. Bull Cancer. 1988;75(2):167-74. Bull Cancer. 1988. PMID: 3282579 Review. French.